AG
TNDM icon

Algert Global’s Tandem Diabetes Care TNDM Stock Holding History

Algert Global’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.56M Buy
235,739
+117,940
+100% +$2.06M 0.04% 668
2026
Q1 		$2.26M Buy
117,799
+8,860
+8% +$193K 0.03% 684
2025
Q4 		$2.39M Sell
108,939
-117,947
-52% -$2.13M 0.04% 663
2025
Q3 		$2.75M Sell
226,886
-304,028
-57% -$4.12M 0.05% 591
2025
Q2 		$9.9M Buy
530,914
+321,594
+154% +$6.37M 0.21% 133
2025
Q1 		$4.01M Buy
209,320
+119,784
+134% +$3.51M 0.1% 348
2024
Q4 		$3.23M Buy
89,536
+52,423
+141% +$1.77M 0.08% 437
2024
Q3 		$1.57M Sell
37,113
-8,150
-18% -$346K 0.04% 637
2024
Q2 		$1.82M Buy
45,263
+6,150
+16% +$257K 0.06% 495
2024
Q1 		$1.38M Buy
39,113
+27,970
+251% +$749K 0.05% 528
2023
Q4 		$330K Sell
11,143
-31,500
-74% -$653K 0.01% 920
2023
Q3 		$886K Buy
42,643
+9,270
+28% +$255K 0.04% 588
2023
Q2 		$819K Sell
33,373
-59,253
-64% -$1.91M 0.04% 700
2023
Q1 		$3.76M Buy
92,626
+27,380
+42% +$1.13M 0.18% 160
2022
Q4 		$2.93M Buy
65,246
+4,065
+7% +$184K 0.16% 182
2022
Q3 		$2.93M Buy
61,181
+2,189
+4% +$120K 0.18% 159
2022
Q2 		$3.49M Buy
58,992
+11,261
+24% +$924K 0.26% 61
2022
Q1 		$5.55M Buy
47,731
+13,412
+39% +$1.57M 0.36% 24
2021
Q4 		$5.17M Sell
34,319
-2,099
-6% -$283K 0.65% 2
2021
Q3 		$4.35M Buy
36,418
+2,338
+7% +$258K 0.58% 3
2021
Q2 		$3.32M Buy
34,080
+19,866
+140% +$1.77M 1.12% 4
2021
Q1 		$1.25M Sell
14,214
-2,969
-17% -$276K 0.4% 82
2020
Q4 		$1.64M Sell
17,183
-20
-0.1% -$2.06K 0.47% 67
2020
Q3 		$1.95M Buy
17,203
+840
+5% +$88.3K 0.62% 39
2020
Q2 		$1.62M Buy
16,363
+11,840
+262% +$945K 0.55% 44
2020
Q1 		$291K Buy
+4,523
New +$317K 0.12% 255

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Algert Global's TNDM Position: Q2 2026 in Review

Algert Global increased its Tandem Diabetes Care (TNDM) stake by 100% in Q2 2026, buying an estimated $2.06M and bringing the position to 235,739 shares worth $3.56M. The position accounts for 0.04% of the portfolio, ranked #668.

Algert Global first reported a position in TNDM in Q1 2020 and has held it in 26 quarters since. The position peaked at $9.9M in Q2 2025. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Algert Global held 235,739 shares of Tandem Diabetes Care worth $3.56M as of Q2 2026.
  • Algert Global bought 117,940 Tandem Diabetes Care shares in Q2 2026, an estimated $2.06M.
  • Tandem Diabetes Care made up 0.04% of Algert Global's portfolio in Q2 2026, its #668 holding.
  • Algert Global first reported a position in Tandem Diabetes Care in Q1 2020 and has held it in 26 quarters since.
  • Algert Global's Tandem Diabetes Care position peaked at $9.9M in Q2 2025.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.